Testing effectiveness (Phase 2)Ended earlyNCT02580708
What this trial is testing
Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung Cancer
Who this might be right for
Non-small Cell Lung Cancer
Clovis Oncology, Inc. 7